SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009400
Filing Date
2024-03-08
Accepted
2024-03-08 16:15:28
Documents
17
Period of Report
2024-03-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42973
2 ex99-1.htm EX-99.1 21154
3 ex99-2.htm EX-99.2 24111
4 ex99-3.htm EX-99.3 15009
  Complete submission text file 0001493152-24-009400.txt   296736

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE maia-20240306.xsd EX-101.SCH 3024
6 XBRL LABEL FILE maia-20240306_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE maia-20240306_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3712
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 24734544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)